0000899243-18-023647.txt : 20180831 0000899243-18-023647.hdr.sgml : 20180831 20180831162057 ACCESSION NUMBER: 0000899243-18-023647 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180829 FILED AS OF DATE: 20180831 DATE AS OF CHANGE: 20180831 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Strum Jay CENTRAL INDEX KEY: 0001706851 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38096 FILM NUMBER: 181050365 MAIL ADDRESS: STREET 1: 79 TW ALEXANDER DRIVE STREET 2: 4501 RESEARCH COMMONS, SUITE 100 CITY: RESEARCH TRIANGLE PARK STATE: NC ZIP: 27709 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: G1 Therapeutics, Inc. CENTRAL INDEX KEY: 0001560241 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 263648180 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 79 T.W. ALEXANDER DRIVE STREET 2: 4501 RESEARCH COMMONS, SUITE 100 CITY: RESEARCH TRIANGLE PARK STATE: NC ZIP: 27709 BUSINESS PHONE: 919-213-9835 MAIL ADDRESS: STREET 1: P. O. BOX # 110341 CITY: RESEARCH TRIANGLE PARK STATE: NC ZIP: 27709 FORMER COMPANY: FORMER CONFORMED NAME: G-Zero Therapeutics, Inc. DATE OF NAME CHANGE: 20121012 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-08-29 0 0001560241 G1 Therapeutics, Inc. GTHX 0001706851 Strum Jay C/O G1 THERAPEUTICS, INC. 79 T.W. ALEXANDER DRIVE RESEARCH TRIANGLE PARK NC 27709 0 1 0 0 Chief Scientific Officer Comomon Stock 2018-08-29 4 S 0 600 58.403 D 57969 D Comomon Stock 2018-08-29 4 S 0 3500 59.10 D 54469 D Comomon Stock 2018-08-29 4 S 0 700 60.004 D 53769 D Comomon Stock 2018-08-29 4 S 0 200 61.00 D 53569 D Comomon Stock 2018-08-30 4 S 0 500 59.266 D 53069 D Comomon Stock 2018-08-30 4 S 0 4500 60.054 D 48569 D The price represents the weighted average price with a low of $57.79 and a high of $58.695. The Reporting Person undertakes to provide G1 Therapeutics, Inc., any security holder of G1 Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnotes 1 through 6. The price represents the weighted average price with a low of $58.80 and a high of $59.72. The price represents the weighted average price with a low of $59.88 and a high of $60.14. The price represents the weighted average price with a low of $60.95 and a high of $61.05. The price represents the weighted average price with a low of $58.65 and a high of $59.58. The price represents the weighted average price with a low of $59.68 and a high of $60.33. /s/ Brian Shea, attorney-in-fact 2018-08-31